Aurinia Pharmaceuticals (NASDAQ:AUPH) Downgraded by Oppenheimer Holdings Inc. to Market Perform

Aurinia Pharmaceuticals} stock has undergone multiple analysts rating changes in the recent past.  Aurinia Pharmaceuticals Downgraded by Oppenheimer Holdings Inc. on 10/28/2021. In a note to investors, the firm issued a new rating of Market Perform. The analysts previously had rating of Outperform.

View More Aurinia Pharmaceuticals (NASDAQ:AUPH) Downgraded by Oppenheimer Holdings Inc. to Market Perform

Aurinia Pharmaceuticals (NASDAQ:AUPH) Target Raised by Royal Bank of Canada to $34.00

StockMarketDaily.co reports: Aurinia Pharmaceuticals stock has undergone multiple analysts rating changes in the recent past.  Aurinia Pharmaceuticals stock Target Raised by   Royal Bank of Canada on 10/26/2021. In a note to investors, the firm issued a new target price of $34.00. The analysts previously had $23.00 target price.

View More Aurinia Pharmaceuticals (NASDAQ:AUPH) Target Raised by Royal Bank of Canada to $34.00

Aurinia Pharmaceuticals (AUPH) Downgraded by Zacks Investment Research to Sell

Aurinia Pharmaceuticals} stock has undergone multiple analysts rating changes in the recent past.  Aurinia Pharmaceuticals Downgraded by Zacks Investment Research on 10/11/2021. In a note to investors, the firm issued a new rating of Sell. The analysts previously had rating of Hold.

View More Aurinia Pharmaceuticals (AUPH) Downgraded by Zacks Investment Research to Sell

Will stock surge before Earnings results? Aurinia Pharmaceuticals (NASDAQ:AUPH)

Earnings results for Aurinia Pharmaceuticals , Analyst Opinion on Aurinia Pharmaceuticals , Earnings and Valuation of (NASDAQ:AUPH), Stock market Insights & financial analysis, Best stock to invest, Investment Idea,

View More Will stock surge before Earnings results? Aurinia Pharmaceuticals (NASDAQ:AUPH)

Should you short it before the Earnings result? : Aurinia Pharmaceuticals (NASDAQ:AUPH)

Earnings results for Aurinia Pharmaceuticals , Analyst Opinion on Aurinia Pharmaceuticals , Earnings and Valuation of (NASDAQ:AUPH), Stock market Insights & financial analysis, Best stock to invest, Investment Idea,

View More Should you short it before the Earnings result? : Aurinia Pharmaceuticals (NASDAQ:AUPH)